Integra LifeSciences
IART
144 hedge funds and large institutions have $1.3B invested in Integra LifeSciences in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 54 increasing their positions, 45 reducing their positions, and 17 closing their positions.
88% more call options, than puts
Call options by funds: $719K | Put options by funds: $382K
20% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 45
5% more capital invested
Capital invested by funds: $1.24B → $1.3B (+$63.2M)
6% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 17
2% less funds holding
Funds holding: 147 → 144 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
+$37.3M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$14.8M |
| 3 |
Goldman Sachs
New York
|
+$11.9M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$6.35M |
| 5 |
GAM
Gotham Asset Management
New York
|
+$6.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
-$29.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$18.7M |
| 3 |
DM
Deerfield Management
New York
|
-$17.4M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$11M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$9.8M |
IART Hedge Fund Activity: Q3 2014 in Review
144 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2014, worth a combined $1.3B — up 5.1% from $1.24B a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of IART and 16 opened new positions — a net loss of 1 holder — while 45 trimmed existing stakes and 54 added.
The largest buyer was Westwood Holdings Group, opening a new position worth an estimated $37.3M. The largest seller was Boston Partners, cutting an estimated $29.3M.
- 144 institutional investors held Integra LifeSciences (IART) as of Q3 2014, down from 147 in Q2 2014.
- Funds reported $1.3B of Integra LifeSciences stock for Q3 2014, up 5.1% quarter-over-quarter.
- 16 funds opened new Integra LifeSciences positions in Q3 2014 and 17 closed out, a net change of -1 holder.
- The largest Integra LifeSciences buyer in Q3 2014 was Westwood Holdings Group, an estimated $37.3M added.
- The largest Integra LifeSciences seller in Q3 2014 was Boston Partners, an estimated $29.3M sold.
Based on aggregated 13F filings for Q3 2014.